Systems and Methods for Determining Tissue Inflammation Levels
AssigneeTufts Medical Center, Inc.
InventorsPedram Hamrah, William Warr Binotti, Ricardo Menon Nose
Life of this patent
Estimating the term…
Abstract
Disclosed are methods, systems, media, apparatus, devices, and other implementations, including a method that includes determining blood flow characteristics at an ocular surface of an eye of a patient, determining characteristics of blood vessels at the ocular surface of the eye based on the determined blood flow characteristics, and deriving one or more ocular redness grading scales indicative of inflammation levels of the eye of the patient based on the determined characteristics of the blood vessels at the ocular surface of the eye.
Claims29
A method comprising:
- determining blood flow characteristics at an ocular surface of an eye of a patient;
- determining characteristics of blood vessels at the ocular surface of the eye based on the determined blood flow characteristics;
- and
- deriving one or more ocular redness grading scales indicative of inflammation levels of the eye of the patient based on the determined characteristics of the blood vessels at the ocular surface of the eye.
A system to determine inflammation level of an eye of a patient, the system comprising:
- an imaging apparatus to determine blood flow characteristics at an ocular surface of the eye of the patient;
- and
- a controller configured to:
- determine characteristics of blood vessels at the ocular surface of the eye based on the determined blood flow characteristics;
- and
- derive one or more ocular redness grading scales indicative of inflammation levels of the eye of the patient based on the determined characteristics of the blood vessels at the ocular surface of the eye.
The system of 18, wherein the controller to perform AS-OCTA imaging for the ocular surface is configured to:
- controllably adjust focus of a lens assembly coupled to an OCT imaging apparatus based on one or more of:
- controllably actuating a focus-motor of the OCT imaging apparatus, or controllably actuating a z-motor of the OCT imaging apparatus to control the distance between the lens assembly and the eye of the patient.
The system of 18, wherein the controller to perform AS-OCTA for the ocular surface is configured to:
- controllably actuate activation and de-activation of the optical emission source provided to the OCT imaging apparatus.
Non-transitory computer readable media comprising computer instructions, executable on one or more processor-based devices, to:
- determine blood flow characteristics at an ocular surface of an eye of a patient;
- determine characteristics of blood vessels at the ocular surface of the eye based on the determined blood flow characteristics;
- and
- derive one or more ocular redness grading scales indicative of inflammation levels of the eye of the patient based on the determined characteristics of the blood vessels at the ocular surface of the eye.
Dependencies are inferred from the claim text.